| [1] |
Menke A, Casagrande S, Geiss L, et al. Prevalence of and trends in diabetes among adults in the united states, 1988-2012 [J]. JAMA, 2015, 314(10):1021-1029.
|
| [2] |
Tesfaye S. Recent advances in the management of diabetic symmetrical poly-neuropathy [J]. J Diabetes Investig, 2011, 24, 2(1):33-42.
|
| [3] |
Jaiswal M,Divers J, DabeleaD, et al. Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for Diabetes in Youth Study [J]. Diabetes Care, 2018, 41(3):e37.
|
| [4] |
Shoaib A, Siddiqui HH, Dixit RK, et al. Current pharmacotherapeutic approaches to treat diabetic neuropathy [J]. J Chem Pharm Res, 2016,8:449-458.
|
| [5] |
Shun CT, Chang YC, Wu HP, et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments [J]. Brain, 2004, 127(pt7): 1593-1605.
|
| [6] |
Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: A position statement by the American Diabetes Association [J]. Diabetes Care, 2017, 40(1): 136-154.
|
| [7] |
董荣芳,张铭,郑丹枫,等.糖尿病周围神经病的病理学研究[J].诊断病理学杂志, 2015,(3):133-138.
|
| [8] |
栾松,崔丽英,汤晓芙,等.糖尿病周围神经病运动神经传导速度分布[J].中华神经科杂志, 2006,(7):436-439.
|
| [9] |
Mehra S, Tavakoli M, Kallinikos PA, et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes [J]. Diabetes Care, 2007, 30(10): 2608-2612.
|
| [10] |
Dyck PJ, Karnes JL, O'Brien P, et al. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia [J]. Ann Neurol, 1986, 19(5): 440-449.
|
| [11] |
Scherer SS. Finding the causes of inherited neuropathies [J]. Arch. Neurol, 2006, 63(6), 812-816.
|
| [12] |
Morrison BM, Tsingalia A, Vidensky S, et al. Deficiency in monocarboxylate transporter 1 （MCT1） in mice delays regeneration of peripheral nerves following sciatic nerve crush [J]. Exp Neurol, 2015, 263:325-338.
|
| [13] |
Domenech-Estevez E, Baloui H, Repond C, et al. Distribution of monocarboxylate transporters in the peripheral nervous system suggests putative roles in lactate shuttling and myelination [J]. J Neurosci, 2015, 35(10): 4151-4156.
|
| [14] |
Busik JV, Tikhonenko M, Bhatwadekar A, et al. Diabetic neuropathy is associated with bone marrow neuropathy and a depressed peripheral clock [J]. J Exp Med, 2010, 206(3): 2897-2906.
|
| [15] |
Sugimoto K, Yasujima M, Yagihashi S. Role of advanced glycation end products in diabetic neuropathy [J]. Curr Pharm Des, 2008, 14(10): 953-961.
|
| [16] |
Brownlee M. Biochemistry and molecular cell biology of diabetic complica-tions [J]. Nature, 2001, 414(6865):813-820.
|
| [17] |
Haupt E, Ledermann H, Kpcke W. Benfotiamine in the treatment of diabetic polyneuropathy-a three-week randomized, controlled pilot study （BEDIP study） [J]. Int J Clin Pharmacol Ther, 2005, 43(2): 71-77.
|
| [18] |
Eichberg J. Protein kinase C changes in diabetes: is the concept relevant to neuropathy? [J]. Int Rev Neurobiol, 2002, 50:61-82.
|
| [19] |
Ryan GJ. New pharmacologic approaches to treating diabetic retinopathy [J]. Am J Health Syst Pharm, 2007, 17(Suppl 12): S15-S21.
|
| [20] |
Yagihashi S, Yamagishi SI, Mizukami H, et al. Escape phenomenon from polyol pathway to other metabolic cascades may underlie nerve conduction delay in severely hyperglycemic AR-deficient mice [C]. 68th American Diabetes Association, San Francisco, USA, June 6-10, 2008.
|
| [21] |
Grewal AS, Bhardwaj S, Pandita D, et al. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases [J]. Mini Rev Med Chem, 2016, 16(2):120-162.
|
| [22] |
Singh R, Kishore L, Kaur N. Diabetic peripheral neuropathy: Current perspective and future directions [J]. Pharmacol Res, 2014, 80: 21-35.
|
| [23] |
Tomlinson DR. Mitogen-activated protein kinases as glucosetransducers fordiabetic complications[J]. Diabetologia, 1999(11), 42:1271-1281.
|
| [24] |
Vareniuk I, Pavlov IA, Obrosova IG. Inducible nitric oxide synthasegene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes [J]. Diabetologia, 2008, 51(11):2126-2133.
|
| [25] |
Smith AG, Singleton JR. Diabetic neuropathy [J]. Continuum Lifelong Learning Neurol, 2012, 18(1):60-84.
|
| [26] |
Yagihashi S, Yamagishi S, Wada R. Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms [J]. Diabetes Res Clin Pract, 2007, 77(Suppl 1): S184-S189.
|
| [27] |
Sagara M, Satoh J, Wada R, et al. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine [J]. Diabetologia, 1996, 39(3):263-269.
|
| [28] |
Kobayashi M, Zochodne DW. Diabetic neuropathy and the sensory neuron: New aspects of pathogenesis and their treatment implications [J]. J Diabetes Investig, 2018,9(6):1239-1254.
|
| [29] |
Liu XS, Fan B, Szalad A, et al. MicroRNA-146a Mimics Reduce the Peripheral Neuropathy in Type 2 Diabetic Mice [J]. Diabetes, 2017, 66(12):3111-3121.
|
| [30] |
Wu Y, Xu D, Zhu X, et al. MiR-106a Associated with Diabetic Peripheral Neuropathy Through the Regulation of 12/15-LOX-meidiated Oxidative/Nitrative [J]. Curr Neurovasc Res, 2017, 14(2):117-124.
|
| [31] |
Luo L, Ji LD, Cai JJ, et al. Microarray analysis of long noncoding rnas in female diabetic peripheral neuropathy patients [J]. Cell Physiol Biochem, 2018, 46(3):1209-1217.
|
| [32] |
Liu C, Tao J, Wu H, et al. Effects of LncRNA BC168687 siRNA on diabetic neuropathic pain mediated by P2X7 receptor on SGCs in DRG of rats [J]. Biomed Res Int, 2017, 2017:7831251.
|
| [33] |
Yu W, Zhao GQ, Cao RJ, et al. LncRNA NONRATT021972 was associated with neuropathic pain scoring in patients with type 2 diabetes [J]. Behav Neurol, 2017, 2017:2941297.
|
| [34] |
Sun L, Ma J, Mao Q, et al. Association of single nucleotide polymorphisms in CACNA 1A/CACNA 1C/CACNA 1H calcium channel genes with diabetic peripheral neuropathy in chinese population [J]. Biosci Rep, 2018, pii: BSR20171670.
|
| [35] |
Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications [J]. Circ Res, 2010, 106(8): 1319-1331.
|
| [36] |
Nakamura J, Kato K, Hamada Y, et al. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats [J]. Diabetes, 1999, 48(10):2090-2095.
|
| [37] |
Yamagishi S, Uehara K, Otsuki S, et al. Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice [J]. J Neurochem, 2003, 87(2): 497-507.
|
| [38] |
Kamiya H, Nakamura J, Hamada Y, et al. Polyol pathway and protein kinase C activity of rat Schwannoma cells [J]. Diabetes Metab Res Rev, 2003, 19(2): 131-139.
|
| [39] |
Witzel II, Jelinek HF, Khalaf K, et al. Identifying common genetic risk factors of diabetic neuropathies [J]. Front Endocrinol （Lausanne）, 2015, 28, 6:88.
|
| [40] |
Pham VM, Tu NH, Katano T, et al. Impaired peripheral nerve regeneration in type-2 diabetic mouse model [J]. Eur J Neurosci, 2018, 47(2):126-139.
|
| [41] |
Waldbillig RJ, LeRoith D. Insulin receptors in the peripheral nervous system: a structural and functional analysis [J]. Brain Res, 1987, 409(2):215-220.
|
| [42] |
Zochodne DW. Mechanisms of diabetic neuron damage: Molecular pathways [J]. Handb Clin Neurol, 2014, 126:379-399.
|
| [43] |
Wang Y, Schmelzer JD, Schmeichel A,et al. Ischemia-reperfusion injury of peripheral nerve in experimental diabetic neuropathy [J]. J Neurol Sci, 2004, 227(1):101-107.
|
| [44] |
Zhang AC, MacIsaac RJ, Roberts L, et al. Omega-3 polyunsaturated fatty acid supplementation for improving peripheral nerve health: protocol for a systematic review [J]. BMJ Open, 2018, 8(3):e020804.
|
| [45] |
Shoaib A, Dixit RK, Badruddeen, et al. Cure of human diabetic neuropathy by HPLC validated bark extract of Onosma echioides L. root [J]. Nat Prod Res, 2018, 9:1-5.
|
| [46] |
Wang Q, Guo ZL, Aori GL, et al. Danhong injection alleviates mechanical allodynia via inhibiting ERK1/2 activation and elevates bdnf level in sciatic nerve in diabetic rat [J]. Evid Based Complement Alternat Med, 2018, 14:5798453.
|
| [47] |
Abdelrahman SA, Samak MA, Shalaby SM. Fluoxetine pretreatment enhances neurogenic, angiogenic and immunomodulatory effects of MSCs on experimentally induced diabetic neuropathy [J]. Cell Tissue Res, 2018, 374(1):83-97.
|
| [48] |
Li R, Ma J, Wu Y, et al. Dual Delivery of NGF and bFGF coacervater ameliorates diabetic peripheral neuropathy via inhibiting schwann cells apoptosis [J]. Int J Biol Sci, 2017, 13(5):640-651.
|
| [49] |
Gholami F, Nikookheslat S, Salekzamani Y, et al. Effect of aerobic training on nerve conduction in men with type 2 diabetes and peripheral neuropathy: A randomized controlled trial [J]. Neurophysiol Clin, 2018, 48(4):195-202.
|